MODULATION OF CD20 EXPRESSION ON B CELLS BY ANTI-CD20 ANTIBODIES

被引：0
|
作者：
Bellintani, Elaine C. [1 ]
de Marco, Renato [1 ]
Fantini, Renata [1 ]
Valim, Tiago [1 ]
Macedo, Denise [1 ]
Miyamoto, Yuriko [1 ]
Temin, Julia [1 ]
Gerbase-DeLima, Maria [1 ]
机构：
[1] AFIP, Immunogenet, Sao Paulo, Brazil
来源：
HUMAN IMMUNOLOGY | 2016年 / 77卷
关键词：
D O I：
10.1016/j.humimm.2016.07.203
中图分类号：
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号：
100102 ;
摘要：
P138
引用
收藏
页码：138 / 138
页数：1
相关论文
共 50 条
  • [21] Development of an SPR-based binding assay for characterization of anti-CD20 antibodies to CD20 expressed on extracellular vesicles
    Wang, Xiangdan
    Phan, Minh Michael
    Sun, Yonglian
    Koerber, James T.
    Ho, Hoangdung
    Chen, Yongmei
    Yang, Jihong
    [J]. Analytical Biochemistry, 2022, 646
  • [22] Unexpected and persistent depletion of B lymphocytes CD20 following a minimum dose of anti-CD20 antibody (Rituximab)
    Bruzzese, V.
    Pepe, J.
    [J]. REUMATISMO, 2009, 61 (04) : 306 - 308
  • [23] A novel pathway regulating CD20 level influence of the inhibition of HDAC6 on the efficacy of anti-CD20 antibodies
    Bobrowicz, M.
    Dwojak, M.
    Bojarczuk, K.
    Siernicka, M.
    Winiarska, M.
    [J]. FEBS JOURNAL, 2014, 281 : 239 - 240
  • [24] Redistribution of CD20 and Fcγ receptor IIb (CD32b) into lipid rafts is important for internalisation of CD20 upon ligation with type I anti-CD20 mAbs
    Vaughan, A. T.
    Lim, S. H.
    Beers, S. A.
    Glennie, M. J.
    Cragg, M. S.
    [J]. IMMUNOLOGY, 2011, 135 : 189 - 189
  • [25] Deleting Malignant B Cells With Second-Generation Anti-CD20 Antibodies
    Sopp, Josh
    Cragg, Mark S.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (22) : 2323 - +
  • [26] The role of antigenic modulation in controlling the efficacy of anti-CD20 monoclonal antibodies
    Beers, S. A.
    Chan, C. H. T.
    James, S.
    French, R. R.
    Attfield, K. E.
    Brennand, C. M.
    Ahuja, A.
    Shlomchik, M.
    Cragg, M. S.
    Glennie, M. J.
    [J]. IMMUNOLOGY, 2008, 125 : 48 - 49
  • [27] Modulation of IgD and CD20 by ligation of CD5 on tonsillar B cells
    Morikawa, K
    Torii, I
    Morikawa, S
    [J]. SCANDINAVIAN JOURNAL OF IMMUNOLOGY, 2002, 55 (01) : 44 - 52
  • [28] Low Levels of Surface CD20 Expression on B220low Immature B-Cells Are Responsible for B-Cell Resistance to Anti-CD20 Treatment.
    Wu, G.
    Todo, T.
    Chai, N. -N.
    Jordan, S.
    Klein, A.
    [J]. AMERICAN JOURNAL OF TRANSPLANTATION, 2012, 12 : 277 - 277
  • [29] Anti-CD20 monoclonal antibodies in multiple sclerosis
    Moreno Torres, Irene
    Garcia-Merino, Antonio
    [J]. EXPERT REVIEW OF NEUROTHERAPEUTICS, 2017, 17 (04) : 359 - 371
  • [30] Anti-CD20 monoclonal antibodies: reviewing a revolution
    Casan, J. M. L.
    Wong, J.
    Northcott, M. J.
    Opat, S.
    [J]. HUMAN VACCINES & IMMUNOTHERAPEUTICS, 2018, 14 (12) : 2820 - 2841
12345